Recent News

By Category: Research

Specific Technologies Detects and Identifies Potential Bioterrorism Pathogenic Bacteria

(PR Newswire) Specific Technologies, today announced the publication of results of the first study demonstrating detection of pathogenic bacteria, including potential bioterrorism agents such as Yersinia pestis and Bacillus anthracis which feature on the Center for Disease Control and Prevention’s list of potential bio-threats.

May 22, 2013
| Filed under Bioterrorism, Countermeasures, and Research
Share

Yellow fever vaccination booster not needed

(WHO) The yellow fever ‘booster’ vaccination given ten years after the initial vaccination is not necessary, according to WHO. An article published in WHO’s Weekly Epidemiological Record (WER) reveals that the Organization’s Strategic Advisory Group of Experts on immunization (SAGE) has reviewed the latest evidence and concluded that a single dose of vaccination is sufficient Read More »

May 22, 2013
| Filed under International, Public Health, and Research
Share

Test IDs All Foot-and-Mouth Virus Serotypes

(Laboratory Equipment) U.S. Department of Agriculture (USDA) scientists have developed a new cell line that rapidly and accurately detects foot-and-mouth disease virus (FMDV), which causes a highly contagious and economically devastating disease in cattle and other cloven-hoofed animals.The cell line was created by Agricultural Research Service (ARS) scientists at the Plum Island Animal Disease Center, Read More »

May 22, 2013
| Filed under Agriculture, Biosafety, and Research
Share

Singapore’s First Home-Grown Influenza Vaccine In Phase 1 Clinical Trial

(Medical News Today) Singapore’s Agency for Science, Technology and Research (A*STAR) and Switzerland’s Cytos Biotechnology AG today announced that the first healthy volunteer has been dosed in a Phase 1 clinical trial with their H1N1 influenza vaccine candidate based on Cytos’ proprietary bacteriophage Qbeta virus-like particle (VLP) technology.

May 22, 2013
| Filed under International and Research
Share

Lawrence Livermore Announces Licensing Opportunity for Fast PCR Technology

(Global Biodefense) Lawrence Livermore National Laboratory (LLNL), operated by the Lawrence Livermore National Security (LLNS), LLC under contract with the U.S. Department of Energy, is offering an opportunity to license intellectual property for a new Fast PCR Instrument technology for commercialization.